Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Complement component 1q (C1q) is the first subcomponent of the C1 complex, initiating the classical complement pathway. It's a pattern recognition molecule recognizing various targets including pathogens, apoptotic cells, and immune complexes. C1q activates the classical pathway upon binding antigen-antibody complexes, triggering a cascade of events leading to pathogen elimination and inflammation. It also plays a role in phagocytosis and tissue homeostasis.
Modulation of complement activation; enhanced phagocytosis; pattern recognition-mediated immune response
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement Component 1q Subcomponent (C1q).